Prone position ventilation, recruitment maneuver and intravenous zanamivir in severe refractory hypoxemia caused by influenza a (H1N1)

Biatto, Jair F. P; Costa, Eduardo L. V; Pastore, Laerte; Kallás, Esper G; Deheinzelin, Daniel; Schettino, Guilherme.
Clinics ; 65(11): 1211-1213, 2010. graf
Artículo en Inglés | LILACS | ID: lil-571438

Documentos relacionados

  1. Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child.
  2. Antiviral Treatments for Influenza.
  3. Comparative effectiveness of neuraminidase inhibitors in patients with influenza: A systematic review and network meta-analysis.
  4. Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza.
  5. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons.
  6. Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series.
  7. Is Inhaled Zanamivir Non-inferior to Oral Oseltamivir in the Treatment of Outpatients With Influenza?
  8. Response to "Inhaled Zanamivir versus Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study".
  9. Organocatalytic and scalable synthesis of the anti-influenza drugs zanamivir, laninamivir, and CS-8958.
  10. Antiviral therapies for influenza.